IHAM
Integral Health Asset Management Portfolio holdings
AUM
$1.07B
This Quarter Return
-6.53%
1 Year Return
+40.53%
3 Year Return
+328.04%
5 Year Return
+535.34%
10 Year Return
–
AUM
$384M
AUM Growth
+$384M
(+7.1%)
Cap. Flow
+$55.4M
Cap. Flow
% of AUM
14.41%
Top 10 Holdings %
Top 10 Hldgs %
35.81%
Holding
89
New
18
Increased
39
Reduced
11
Closed
17
Top Buys
| 1 |
Elevance Health
ELV
|
$9.82M |
| 2 |
CRISPR Therapeutics
CRSP
|
$7.53M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$7.2M |
| 4 |
Guardant Health
GH
|
$6.62M |
| 5 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$6.22M |
Top Sells
| 1 |
McKesson
MCK
|
$13.7M |
| 2 |
Abbott
ABT
|
$9.85M |
| 3 |
Fate Therapeutics
FATE
|
$7.61M |
| 4 |
AbbVie
ABBV
|
$6.77M |
| 5 |
Centene
CNC
|
$6.31M |
Sector Composition
| 1 | Healthcare | 97.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Elevance Health
ELV
$71.8B
| $22.1M | 5.75% | 45,000 +20,000 | +80% | +$9.82M |
|
2
Cytokinetics
CYTK
$4.23B
| $17.3M | 4.5% | 470,000 +145,000 | +45% | +$5.34M |
|
3
Pfizer
PFE
$141B
| $15.5M | 4.04% | 300,000 +100,000 | +50% | +$5.18M |
|
4
Globus Medical
GMED
$8.27B
| $13.3M | 3.46% | 180,000 | – | – |
|
5
Revvity
RVTY
$10.5B
| $13.1M | 3.4% | 75,000 +5,000 | +7% | +$872K |
|
|
6
Centene
CNC
$14.3B
| $12.6M | 3.29% | 150,000 -75,000 | -33% | -$6.31M |
|
7
Envista
NVST
$3.52B
| $12.2M | 3.17% | 250,000 -50,000 | -17% | -$2.44M |
|
8
Tenet Healthcare
THC
$16.3B
| $11.2M | 2.91% | 130,000 +50,000 | +63% | +$4.3M |
|
|
SAGE
9
DELISTED
Sage Therapeutics
SAGE
| $10.3M | 2.68% | 311,000 -98,000 | -24% | -$3.24M |
|
|
CCXI
10
DELISTED
ChemoCentryx, Inc.
CCXI
| $10M | 2.61% | 400,000 +200,000 | +100% | +$5.01M |
|
11
Zentalis Pharmaceuticals
ZNTL
$122M
| $9.92M | 2.58% | 215,000 +95,000 | +79% | +$4.38M |
|
12
Acadia Healthcare
ACHC
$2.12B
| $9.83M | 2.56% | 150,000 +30,000 | +25% | +$1.97M |
|
13
Relay Therapeutics
RLAY
$619M
| $9.79M | 2.55% | 327,000 +102,000 | +45% | +$3.05M |
|
|
BPMC
14
DELISTED
Blueprint Medicines
BPMC
| $9.77M | 2.54% | 153,000 +78,000 | +104% | +$4.98M |
|
15
iRhythm Technologies
IRTC
$5.46B
| $9.45M | 2.46% | 60,000 +20,000 | +50% | +$3.15M |
|
16
CVS Health
CVS
$92.8B
| $9.11M | 2.37% | 90,000 +5,000 | +6% | +$506K |
|
|
17
CRISPR Therapeutics
CRSP
$4.71B
| $7.53M | 1.96% | +120,000 | New | +$7.53M |
|
|
SGEN
18
DELISTED
Seagen Inc. Common Stock
SGEN
| $7.2M | 1.87% | +50,000 | New | +$7.2M |
|
|
AMED
19
DELISTED
Amedisys
AMED
| $6.89M | 1.79% | 40,000 -10,000 | -20% | -$1.72M |
|
20
AstraZeneca
AZN
$248B
| $6.63M | 1.73% | 100,000 | – | – |
|
|
21
Guardant Health
GH
$8.41B
| $6.62M | 1.72% | +100,000 | New | +$6.62M |
|
22
Alkermes
ALKS
$4.78B
| $6.58M | 1.71% | 250,000 +200,000 | +400% | +$5.26M |
|
|
SWAV
23
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $6.22M | 1.62% | +30,000 | New | +$6.22M |
|
24
BioMarin Pharmaceuticals
BMRN
$11.2B
| $6.17M | 1.61% | 80,000 +32,000 | +67% | +$2.47M |
|
25
Merck
MRK
$210B
| $6.15M | 1.6% | +75,000 | New | +$6.15M |
|